Literature DB >> 25541164

Effect of empirical treatment on outcomes of clinical trials of diagnostic assays for tuberculosis.

Nicolas A Menzies1, Ted Cohen2, Megan Murray3, Joshua A Salomon4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25541164     DOI： 10.1016/S1473-3099(14)71026-6

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  8 in total

1.  Strengthening health systems to improve the value of tuberculosis diagnostics in South Africa: A cost and cost-effectiveness analysis.

Authors:  Nicola Foster; Lucy Cunnama; Kerrigan McCarthy; Lebogang Ramma; Mariana Siapka; Edina Sinanovic; Gavin Churchyard; Katherine Fielding; Alison D Grant; Susan Cleary
Journal:  PLoS One       Date:  2021-05-14       Impact factor: 3.752

2.  Incorporating Demand and Supply Constraints into Economic Evaluations in Low-Income and Middle-Income Countries.

Authors:  Anna Vassall; Lindsay Mangham-Jefferies; Gabriela B Gomez; Catherine Pitt; Nicola Foster
Journal:  Health Econ       Date:  2016-01-19       Impact factor: 3.046

3.  The impact of the roll-out of rapid molecular diagnostic testing for tuberculosis on empirical treatment in Cape Town, South Africa.

Authors:  Sabine Hermans; Judy Caldwell; Richard Kaplan; Frank Cobelens; Robin Wood
Journal:  Bull World Health Organ       Date:  2017-04-28       Impact factor: 9.408

4.  Cost-effectiveness of Xpert MTB/RIF for tuberculosis diagnosis in South Africa: a real-world cost analysis and economic evaluation.

Authors:  Anna Vassall; Mariana Siapka; Nicola Foster; Lucy Cunnama; Lebogang Ramma; Katherine Fielding; Kerrigan McCarthy; Gavin Churchyard; Alison Grant; Edina Sinanovic
Journal:  Lancet Glob Health       Date:  2017-07       Impact factor: 26.763

Review 5.  Disparities in model-based cost-effectiveness analyses of tuberculosis diagnosis: A systematic review.

Authors:  T I Armina Padmasawitri; Gerardus W Frederix; Bachti Alisjahbana; Olaf Klungel; Anke M Hövels
Journal:  PLoS One       Date:  2018-05-09       Impact factor: 3.240

6.  The impact of HIV and tuberculosis interventions on South African adult tuberculosis trends, 1990-2019: a mathematical modeling analysis.

Authors:  Mmamapudi Kubjane; Muhammad Osman; Andrew Boulle; Leigh F Johnson
Journal:  Int J Infect Dis       Date:  2022-07-21       Impact factor: 12.074

Review 7.  Bridging the gap between evidence and policy for infectious diseases: How models can aid public health decision-making.

Authors:  Gwenan M Knight; Nila J Dharan; Gregory J Fox; Natalie Stennis; Alice Zwerling; Renuka Khurana; David W Dowdy
Journal:  Int J Infect Dis       Date:  2015-11-03       Impact factor: 3.623

8.  Improving the quality of modelling evidence used for tuberculosis policy evaluation.

Authors:  N A Menzies; C F McQuaid; G B Gomez; A Siroka; P Glaziou; K Floyd; R G White; R M G J Houben
Journal:  Int J Tuberc Lung Dis       Date:  2019-04-01       Impact factor: 2.373
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.